West Pharmaceutical Services Income After Taxes 2010-2024 | WST

West Pharmaceutical Services annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • West Pharmaceutical Services income after taxes for the quarter ending June 30, 2024 was $0.107B, a 28.85% decline year-over-year.
  • West Pharmaceutical Services income after taxes for the twelve months ending June 30, 2024 was $0.509B, a 1.82% increase year-over-year.
  • West Pharmaceutical Services annual income after taxes for 2023 was $0.576B, a 1.86% increase from 2022.
  • West Pharmaceutical Services annual income after taxes for 2022 was $0.565B, a 11.92% decline from 2021.
  • West Pharmaceutical Services annual income after taxes for 2021 was $0.642B, a 95.16% increase from 2020.
West Pharmaceutical Services Annual Income After Taxes
(Millions of US $)
2023 $576
2022 $565
2021 $642
2020 $329
2019 $233
2018 $199
2017 $142
2016 $135
2015 $90
2014 $122
2013 $107
2012 $76
2011 $69
2010 $61
2009 $70
West Pharmaceutical Services Quarterly Income After Taxes
(Millions of US $)
2024-06-30 $107
2024-03-31 $111
2023-12-31 $134
2023-09-30 $158
2023-06-30 $150
2023-03-31 $134
2022-12-31 $100
2022-09-30 $116
2022-06-30 $183
2022-03-31 $167
2021-12-31 $148
2021-09-30 $169
2021-06-30 $179
2021-03-31 $146
2020-12-31 $95
2020-09-30 $77
2020-06-30 $86
2020-03-31 $72
2019-12-31 $61
2019-09-30 $54
2019-06-30 $64
2019-03-31 $54
2018-12-31 $51
2018-09-30 $53
2018-06-30 $54
2018-03-31 $41
2017-12-31 $-3
2017-09-30 $49
2017-06-30 $38
2017-03-31 $57
2016-12-31 $37
2016-09-30 $35
2016-06-30 $43
2016-03-31 $21
2015-12-31 $31
2015-09-30 $-0
2015-06-30 $27
2015-03-31 $32
2014-12-31 $30
2014-09-30 $30
2014-06-30 $36
2014-03-31 $26
2013-12-31 $23
2013-09-30 $25
2013-06-30 $29
2013-03-31 $31
2012-12-31 $21
2012-09-30 $13
2012-06-30 $14
2012-03-31 $28
2011-12-31 $17
2011-09-30 $15
2011-06-30 $18
2011-03-31 $18
2010-12-31 $5
2010-09-30 $17
2010-06-30 $20
2010-03-31 $19
2009-12-31 $19
2009-09-30 $16
2009-06-30 $19
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.428B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13